Key Takeaways
- • Hedge funds posted a 2.71% monthly return in May 2020 according to the Barclay Hedge Fund Index, trailing the S&P 500 Total Return Index's 4.76% gain but demonstrating broad recovery momentum following April's pandemic-driven downturn.
- • Year-to-date performance through May showed hedge funds down 4.67% versus the S&P 500's 4.97% decline, indicating relative outperformance during the early stages of the COVID-19 market crisis.
- • Healthcare & Biotechnology emerged as the strongest-performing sector with a 5.74% May return, followed by Technology (4.81%), Pacific Rim Equities (4.62%), Equity Long Bias (4.14%), and Event Driven strategies (4.12%).
- • Only two hedge fund sectors declined in May: Merger Arbitrage fell 0.42% and Equity Market Neutral declined 0.02%, reflecting stress in deal-dependent and market-neutral strategies during pandemic volatility.
- • Market recovery was driven by government and central bank stimulus measures, early reopening signals, and optimism surrounding vaccine development efforts, with oil prices also benefiting from production constraints and renewed business activity.
Summary
Hedge funds captured positive momentum in May 2020 as equity markets rebounded from pandemic-induced losses, delivering a 2.71% monthly return according to BarclayHedge's Barclay Hedge Fund Index. While this performance lagged the S&P 500 Total Return Index's 4.76% monthly gain, hedge funds demonstrated relative resilience on a year-to-date basis, with the industry down 4.67% through May compared to the S&P 500's 4.97% decline. The broader recovery reflected investor confidence bolstered by unprecedented fiscal and monetary stimulus, initial phases of economic reopening, and advancing coronavirus vaccine development efforts.
The May rally was broad-based across hedge fund strategies, with 15 of 17 tracked sectors posting positive returns. Healthcare & Biotechnology led all sectors with a 5.74% gain, capitalizing on accelerating drug development activity and increased government support for pandemic-related medical innovation. Technology stocks followed closely with a 4.81% return, benefiting from accelerated digital adoption trends and work-from-home dynamics. The Pacific Rim Equities Index returned 4.62%, while domestically-focused Equity Long Bias strategies gained 4.14% and Event Driven funds posted 4.12% returns as deal activity resumed following April's uncertainty.
Defensive strategies faced headwinds during the equity-driven rally. The Merger Arbitrage Index declined 0.42% as deal spreads compressed amid renewed M&A confidence, while the Equity Market Neutral Index posted a marginal 0.02% loss as long-short dynamics tightened in a risk-on environment. Sol Waksman, president of BarclayHedge, attributed the sector's resilience to equities' responsiveness to positive catalysts: "Equity markets continued to seize on optimistic news as they rebounded from their initial pandemic downturn, while oil prices responded positively to the combination of production limits and renewed business activity."
The May performance marked a critical inflection point in hedge fund recovery following the severe market disruption of February and March 2020, as coordinated global policy responses and signs of medical progress shifted investor sentiment from pandemic-driven capitulation toward cautious cyclical recovery positioning.
The May rally was broad-based across hedge fund strategies, with 15 of 17 tracked sectors posting positive returns. Healthcare & Biotechnology led all sectors with a 5.74% gain, capitalizing on accelerating drug development activity and increased government support for pandemic-related medical innovation. Technology stocks followed closely with a 4.81% return, benefiting from accelerated digital adoption trends and work-from-home dynamics. The Pacific Rim Equities Index returned 4.62%, while domestically-focused Equity Long Bias strategies gained 4.14% and Event Driven funds posted 4.12% returns as deal activity resumed following April's uncertainty.
Defensive strategies faced headwinds during the equity-driven rally. The Merger Arbitrage Index declined 0.42% as deal spreads compressed amid renewed M&A confidence, while the Equity Market Neutral Index posted a marginal 0.02% loss as long-short dynamics tightened in a risk-on environment. Sol Waksman, president of BarclayHedge, attributed the sector's resilience to equities' responsiveness to positive catalysts: "Equity markets continued to seize on optimistic news as they rebounded from their initial pandemic downturn, while oil prices responded positively to the combination of production limits and renewed business activity."
The May performance marked a critical inflection point in hedge fund recovery following the severe market disruption of February and March 2020, as coordinated global policy responses and signs of medical progress shifted investor sentiment from pandemic-driven capitulation toward cautious cyclical recovery positioning.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.